People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

WalletHub released a new analysis ranking America's most overweight cities, based on obesity rates, health consequences and ...

Oxford Medical Products today announces additional three-month clinical trial results for Sirona, a weight-loss treatment targeting people who are overweight or have class I obesity (BMI 25-35) and ...

Throughout his solo career and his work with NLCC, he has amassed 37 GMWA Excellence Awards, 27 Stellar Awards, three BMI Awards, two Billboard Music Awards, a Soul Train Music Award, a ...

Sirona is a dual-polymer hydrogel pill that expands in the stomach, reducing appetite. Participants consumed 400 fewer ...

Adiponectin levels were associated with increased likelihood of metabolic health improvements and lower risk for diabetes across 6 years.

GLP-1RA discontinuation and lack of reinitiation was more common among patients with obesity and without type 2 diabetes than with type 2 diabetes.

Objective This study aimed to identify body mass index (BMI) growth trajectories from birth to 24 months of age and examine ...

Study adds weight to calls for sugar taxes and food warning labels as obesity threatens economy and public health.

The study used innovative technology that maps RNA molecules which are the basis for translating the genome into proteins.